Health for Life Capital II has achieved its first close thanks to commitments from strategic partners Danone, Novartis, Lesaffre, Wright Medical, Unicéréales and Bel.
France-based venture capital firm Seventure Partners has reached the first close of a €200m ($225m) healthcare-focused fund with commitments from corporate limited partners including cheese producer Bel and food provider Danone.
Pharmaceutical firm Novartis, yeast manufacturer Lesaffre, medical device producer Wright Medical and Unigrains, the investment arm of agricultural products supplier Unicéréales, have also backed the fund.
Health for Life Capital II has also signed up an as-yet unnamed US-based food ingredient provider, undisclosed financial services firms and assorted individual…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
